Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000655275 | SCV000724955 | likely benign | not provided | 2019-11-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001448249 | SCV001651332 | likely benign | Adams-Oliver syndrome 5 | 2024-12-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001448249 | SCV002554433 | likely benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270821 | SCV002554434 | likely benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002325171 | SCV002631449 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-12-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002491273 | SCV002803426 | likely benign | Aortic valve disease 1; Adams-Oliver syndrome 5 | 2021-11-02 | criteria provided, single submitter | clinical testing |